Related Experiment Videos
Interactions among thyroid function, insulin sensitivity, and serum lipid concentrations: the Fremantle diabetes
S A P Chubb1, W A Davis, T M E Davis
1Department of Biochemistry, Fremantle Hospital, P.O. Box 480, Fremantle, Western Australia 6959, Australia. paul.chubb@health.wa.gov.au
The Journal of Clinical Endocrinology and Metabolism
|June 30, 2005
Summary
Insulin sensitivity significantly impacts thyroid dysfunction and lipid levels in diabetic women. Poor insulin sensitivity exacerbates adverse cardiac risk factors linked to thyroid issues, highlighting a key interaction in diabetic dyslipidemia.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Cardiovascular Risk Factors
Background:
- Insulin resistance is known to alter the relationship between serum cholesterol and thyroid function in healthy individuals.
- Understanding this interaction is crucial for managing metabolic and cardiovascular health.
Purpose of the Study:
- To investigate if insulin sensitivity modifies the association between thyroid dysfunction and lipid profiles in patients with type 2 diabetes.
- To explore the interplay between thyroid status, insulin sensitivity, and dyslipidemia in a diabetic population.
Main Methods:
- A cross-sectional, community-based observational study involving 117 females with type 2 diabetes.
- Measurements included serum TSH, insulin, lipids (total cholesterol, HDL, triglycerides), and Homeostasis Model Assessment for Insulin Sensitivity (HOMA-S).
- Age-adjusted multiple linear regression analysis was used to assess relationships.
Main Results:
- A significant interaction between serum TSH and HOMA-S was observed, modifying lipid concentrations.
- At low insulin sensitivity, strong positive associations between TSH and adverse cardiac risk lipid parameters were evident.
- These associations were absent at higher insulin sensitivity levels, particularly for lipid risk factors linked to insulin resistance.
Conclusions:
- The interaction between thyroid function and insulin sensitivity is a significant factor in diabetic dyslipidemia.
- These findings suggest that thyroid hormone replacement therapy might be beneficial for certain diabetic patients with dyslipidemia.